Patrocinados
Actualizaciones Recientes
- Electronic Pill Market Size Estimation, Future Insights, Share Analysis, Growth Statistics and Analysis By 2030Electronic Pill Market Highlights The Electronic Pill Market is anticipated to reach USD 1.00 Billion by 2030 at 6.60% CAGR during the forecast period 2022-2030. The growing prevalence of gastrointestinal diseases, increasing unhealthy food consumption, increase in research and development activities, growing government reimbursement policies, rising geriatric population, increased need for...0 Commentarios 0 Acciones 408 Views 0 Vista previaPlease log in to like, share and comment!
- Computer Vision in Healthcare Market by Key Players, Regions, Company Profile, Growth Opportunity, and Challenges by 2030Computer Vision in Healthcare Market Highlights According to MRFR analysis, the Computer Vision in Healthcare Market is anticipated to grow at a significant rate of 45.20%. Furthermore, the market value is further evaluated to increase up to USD 575.4 Million in the studied forecast period 2022-2030. Computer vision is utilized in diagnosis of various diseases and surgeries. Computer vision...0 Commentarios 0 Acciones 443 Views 0 Vista previa
- Computer Vision in Healthcare Market by Key Players, Regions, Company Profile, Growth Opportunity, and Challenges by 2030Computer Vision in Healthcare Market Highlights According to MRFR analysis, the Computer Vision in Healthcare Market is anticipated to grow at a significant rate of 45.20%. Furthermore, the market value is further evaluated to increase up to USD 575.4 Million in the studied forecast period 2022-2030. Computer vision is utilized in diagnosis of various diseases and surgeries. Computer vision...0 Commentarios 0 Acciones 477 Views 0 Vista previa
- Insulin Biosimilars Market | Analysis, Size, Growth, Key Players, Segmentation and Forecast By 2030Insulin Biosimilars Market Highlights A disease in which the body’s ability to produce or respond to the hormone insulin is impaired, resulting in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood is termed diabetes. Biosimilar insulin is designed to be highly like the original, or reference, insulin product described in a patent. As patents for major...0 Commentarios 0 Acciones 433 Views 0 Vista previa
Quizás te interese…